β1-adrenoceptor polymorphisms and ethnicity independently affect response to atenolol.

被引：0
|
作者：
Kumik, D. [1 ]
Sofowora, G. G. [1 ]
Friedman, E. A. [1 ]
Muszkat, M. [1 ]
Xie, H. G. [1 ]
Harris, P. A. [1 ]
Jiang, L. [1 ]
Williams, S. M. [1 ]
Li, C. [1 ]
Wood, A. J. [1 ]
Stein, C. M. [1 ]
机构：
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S3 / S4
页数：2
相关论文
共 50 条
  • [21] β1-Adrenoceptor polymorphism Gly389Arg affects cardiac response to dobutamine and its attenuation by β-adrenoceptor blockade
    Temme, T
    Bruck, H
    Leineweber, K
    Brodde, OE
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R135 - R135
  • [22] Polymorphisms in the α1A-adrenoceptor gene do not modify the short- and long-term efficacy of α1-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia
    Mochtar, CA
    Laan, W
    Van Houwelingen, KP
    Franke, B
    De la Rosette, JJMCH
    Schalken, JA
    Kiemeney, LALM
    BJU INTERNATIONAL, 2006, 97 (04) : 852 - 855
  • [23] Mechanism-based pharmacodynamic modeling of s(-)-atenolol:: Estimation of in vivo affinity for the β1-adrenoceptor with an agonist-antagonist interaction model
    Van Steeg, Tamara J.
    Freijer, Jan
    Danhof, Meindert
    De lange, Elizabeth C. M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (03): : 1234 - 1242
  • [24] DILATED CARDIOMYOPATHY WITH HYPERTENSION: PREVALENCE AND RESPONSE TO HIGH-DOSE β1-ADRENOCEPTOR ANTAGONIST THERAPY
    Zeng, Xiaolin
    Chen, Shuzhen
    Wang, Jinju
    Yang, Tianlun
    Chen, Yanfang
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2009, 36 (09) : 945 - 949
  • [25] Chronic diabetes and hypertension impair the in vivo functional response to phenylephrine independent of α1-adrenoceptor expression
    Rodriguez, Jessica E.
    Ruiz-Hernandez, Armando
    Hernandez-DiazCouder, Adrian
    Huang, Fengyang
    Hong, Enrique
    Villafana, Santiago
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 883 : 173283
  • [26] Working Mechanism Underlying the Reduction of the Behavioral and Accumbal Dopamine Response to Cocaine by α-1-Adrenoceptor Antagonists
    Verheij, Michel M. M.
    Saigusa, Tadashi
    Koshikawa, Noriaki
    Cools, Alexander R.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 (03) : 540 - 541
  • [27] Working Mechanism Underlying the Reduction of the Behavioral and Accumbal Dopamine Response to Cocaine by α-1-Adrenoceptor Antagonists
    Michel MM Verheij
    Tadashi Saigusa
    Noriaki Koshikawa
    Alexander R Cools
    Neuropsychopharmacology, 2013, 38 : 540 - 541
  • [28] The Arg389Gly β1-adrenoceptor gene polymorphism determines contractile response to catecholamines
    La Rosée, K
    Huntgeburth, M
    Rosenkranz, S
    Böhm, M
    Schnabel, P
    PHARMACOGENETICS, 2004, 14 (11): : 711 - 716
  • [29] Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to 1-adrenoceptor stimulation in vivo
    Puhl, S-L
    Kazakov, A.
    Mueller, A.
    Fries, P.
    Wagner, D. R.
    Boehm, M.
    Maack, C.
    Devaux, Y.
    BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (01) : 88 - 102
  • [30] Effect of Gly389Arg β1-adrenoceptor polymorphism on cardiac response to dobutamine and its attenuation by β-adrenoceptor blockade in the presence of atropine
    Bruck, H
    Temme, T
    Leineweber, K
    Brodde, OE
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R139 - R139
12345